We describe the use of small interfering RNAs (siRNAs) to downregulate H-and L-ferritin levels in HeLa cells. They repressed H-and L-ferritin expression to about 20-25% of the background level, both in stable and transient transfections. HeLa cells transfected with H-and L-
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The biological role of L-ferritin is less clear. Clinical evidence indicates that its constitutive overexpression in subjects with the Hereditary Hyperferritinemia Cataract Syndrome has negligible effects on body iron handling (18) . The disorder is caused by mutations in the IRE sequence of Lferritin messenger which cause a 10-20 fold increase of L-ferritin levels in tissues and serum (19) , but it does not determine evident body iron load or decompartmentalization. It is often associated with early onset of bilateral cataract, likely caused by protein aggregation in the lens (20) . These data are in partial contradiction with indications that HeLa cells transfected with L-ferritin cDNA have a reduced ROS production (21) , and that antisense L-chain inhibition expanded the labile iron pool similarly to H-ferritin inhibition (14, 15) . Thus, L-chain may participate in the regulation of cellular iron availability, as it was proposed by the early findings that the L: H ratio is strictly regulated in a tissue specific manner (22) and that it changes in iron-loaded organs (23) .
Here we report the use of small interfering RNAs (siRNAs) as a recent tool to downregulate ferritin levels in HeLa cells more efficiently than antisense DNAs, and evaluate their effects in comparison those obtained by upregulating the ferritin via cDNA transfection. The results show that: a) the modifications of L-ferritin levels do not affect iron availability in HeLa cells, but positively affect cell proliferation rates in an iron independent manner; b) the transient downregulation of H-ferritin modifies cellular iron availability and resistance to oxidative damage, as expected, c) the stable reduction of H-ferritin in HeLa cell clones transfected with siRNAs did not increase cell iron availability, but made cells less resistant to iron supplementation and chelation, consistent with the notion that H-ferritin acts as an iron buffer.
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Cell culture and analysis. The stable HeLa cell H-and L-clones that express ferritin H-and L-wild type under the control of the tetracycline promoter were described in refs (13, 17) . In the presence of 2 ng/ml doxycycline (Sigma, St Louis, MO) (dox+) the exogenous ferritin expression was repressed, whereas in the absence, it was induced (dox-). To evaluate the cell proliferation rate, the HeLa cells were grown for 40 h, counted and 10 4 cells were plated in 96 wells culture plates (Greiner, Sarah, St. Longwood, USA). They were grown for other 18 h at 37°C in 0.1 ml medium, then 10 µl of MTT solution (5mg/ml in phosphate-buffered saline) were added and after 3 h the developed color was read at 570 mm (13) Metabolic labeling and immunoprecipitation. HeLa cells were metabolically labeled as described in ref (11) . Briefly, 5x10 5 cells were grown for 1 h in DMEM without methionine and cysteine (ICN Biomedicals Inc, Costa Mesa, CA), 0.5% bovine serum albumin, then added with 50 µCi/ml The immunobeads were collected, loaded on 12% polyacrylamide SDS-PAGE, and exposed to autoradiography.
Biochemical and immunological methods. Ferritin levels were determined with ELISA assay using the monoclonal antibody rH02 (specific for the H-ferritin) or L03 (specific for the L-ferritin) calibrated on the corresponding recombinant homopolymer (26) . Protein concentration was Francisco, CA), with rabbit anti-PARP p85 fragment (1:500) (Promega, Madison, WI) or with mouse anti-H-ferritin subunit (HS59) (1:500) (27) followed by secondary peroxidase-labeled antibody (Sigma, St Louis, MO). Bound activity was revealed by ECL (Amersham, Uppsala, Sweden). IRPs activity was evaluated by electromobility shift assays as in ref. (11) . Cells (2x10 5 ) were grown for 18 h, lysed, and 2 µg samples of soluble proteins were incubated with a molar excess of 32 P-labeled H-ferritin IRE probe, RNase T1, and heparin in the presence or the absence of 2% 2-mercaptoethanol. RNA protein complexes were separated on 6% non-denaturing PAGE and exposed to autoradiography. The intensity of IRE-IRP band was quantified by densitometry in the linear range.
Results

Production and analysis of siRNAs for H-and L-ferritins.
We produced double-strand (ds) siRNAs targeting 4 different regions of the coding regions of HmRNA and of L-ferritin mRNA. They were chosen manually for being 19 nt long, having 5'G and 3'C termini, for a GC content < 60% and for being as separated as possible within the coding sequence. In BLAST analysis on human genome the sequences hit only the corresponding ferritin gene and some ferritin pseudo genes, but not the mitochondrial ferritin sequence. The RNAs were transcribed in vitro, annealed and used for transfection as described in ref (24) . HeLa cells were transfected with various amounts of ds-siRNAs, harvested 40 h later, and H-and L-ferritin content was analyzed by specific ELISA assays. The 4 ds-siRNAs for H-ferritin reduced H-ferritin levels in a dose-dependent manner to about 20-25% of the background level (Fig. 1A) , and this was accompanied by a dose-dependent increase of L-ferritin to about 3 fold over background ( Table I ).
The 4 ds-siRNAs for L-ferritin reduced L-ferritin level in a dose dependent manner; one was less effective (up to 60% reduction) while the other three behaved similarly with a reduction to about 20-25% of the background (Fig 1B) without affecting H-ferritin level (Table I) . Using 1.6 µg siRNAs, H-ferritin level decreased from ~390 ng/mg protein to ~100 ng/mg, and L-ferritin level from ~75 to ~16 ng/mg (Table I) . Maximum inhibition occurred between day 2 and 3 after transfection, then it increased ( Fig. 1 C) , as already reported for other proteins (28) . The use of fluorescent-labeled control (non-silencing) siRNA showed that our conditions yielded a transfection efficiency > 95%, in agreement with reported data (29) . The results indicate that siRNAs are effective in reducing ferritin content, and that they are specific, since downregulate only the targeted ferritins.
Modulation of L-ferritin expression.
As an approach to study L-ferritin biological functions, we used L-siRNA1 and a HeLa cell clone (L-clone) transfected with L-ferritin cDNA under the control of the inducible tetracycline promoter (17) . In the presence of the suppressor doxycycline, L-ferritin level was analogous to that of the untransfected parent cells, while after withdrawal of it, L-ferritin level increased about 3-fold (Table   I) . Thus, the transfections with L-siRNA and with L-cDNA modified L-ferritin from 16 to 215 ng/mg of total proteins, more than 13-fold range. However, H-ferritin remained at a level of ~400 ng/mg proteins after both modifications, as in the non-transfected parent cells (Table I) . Also IRPs activity, determined by EMSA assay ( Fig. 2A) , and TfR1 level, determined by blotting ( Fig. 2B) were analogous in the control, L-siRNA transfected cells and in the induced L-clone. Thus, the variation of L-ferritin content did not modify iron availability indices. Next, we analyzed cell resistance to H 2 O 2 and cellular proliferation rates, which are strongly affected by H-ferritin
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Opposite, L-siRNA transfection caused a decrease of proliferation rate to about 50% (Fig. 4A) . The observation was confirmed by an alternative method: total cellular protein after growing 10 5 cells for 18 h was about the 50% higher in the induced L-clone than in the controls, while it was about the 40% lower in the L-siRNA transfected cells. In addition, we found that transfection with HsiRNA alone caused ~20% increase of MTT assay, while the co-transfection with H-and L-siRNAs caused ~ 80% reduction of it, which is even higher than that caused by L-siRNA alone (Fig. 4C ).
The inhibitory proliferation effect of H-ferritin overexpression is iron-mediated and is abolished by prolonged iron supplementation (13) . Thus, we incubated the cells with 0.1 mM FAC for 24 h before MTT assay, as before (13) . However, the treatment did not modify cell proliferation in the control, L-siRNA transfected, un-induced and induced L-clone (Fig. 4A ). In conclusion, we found that L-ferritin level does not affect any of the major parameters of iron availability, but regulates cell proliferation in a direction and with a mechanism that is different from that caused by the variation of H-ferritin levels.
Modulation of H-ferritin expression.
We first studied the properties of HeLa cells transiently transfected with H-siRNAs. H-ferritin inhibition was accompanied by a ~ 3-fold increases of L-ferritin levels (Table I) , a ~ 50% reduction of IRPs activity ( Fig. 2A) and a ~ 80% decrease of TfR1 level (Fig. 2B) . The additional cotransfection with L-siRNA1 inhibited L-ferritin (Table I) , modified only marginally IRPs activity, while further decreased TfR1 expression ( Fig. 2A and B) . Next we analyzed the resistance to H 2 O 2 by MTT assay (Fig. 3B) , and we found it to be largely decreased, as expected, an effect particularly evident at 600 µM H 2 O 2 , the condition in which H-ferritin overexpression was the most protective (13) . All together the findings confirm that H-ferritin levels regulate iron availability (13, 15) . Then, we tried to produce clones in which H-ferritin was stably suppressed. To this aim we cloned the sequences of the H-siRNA3 in a hairpin structure into the vector pSilencer1.0-U6 and verified that its transfection caused a significant reduction of H-ferritin (not shown). The plasmid (1.8 µg) was co-transfected with 0.5 µg pTK-Hyg plasmid (5:1 molar ratio) carrying hygromycine resistance, and clones were selected after growth in 150 µg/ml hygromycine. ELISA assay identified 26 clones with low H-ferritin levels, and two of them, H1 and H2 were chosen for further analysis. The Hferritin concentration was reduced to about 25% of the control, as in the H-ds-siRNA transfected (Table I) . Surprisingly, the stable H-ferritin reduction in H1 clone was accompanied by a marginal 20% increase of L-ferritin, while the transient H-ferritin reduction caused a much higher, 3-fold, induction of L-ferritin (Table I) . ELISA assays showed analogous levels of H-and Lferritins in the H1 clone (98 and 97 ng/mg protein, respectively, Table I ) and immunoprecipitation experiments of metabolically labeled cells confirmed that ferritin in the clone was composed by equal amounts of H-and L-subunit (Fig. 5A ). In addition, we found that TfR1 levels (Fig. 5B) and MTT proliferation rate of the clone (Fig. 5C) were analogous to the values of the untransfected parent cells. Thus, the stable H-ferritin suppression did not cause the expected increase of iron cellular availability. The only abnormal biochemical finding in H1 and H2 clones was the spontaneous accumulation of p85 PARP peptide, a product of caspase activity considered an index of apoptosis (Fig. 6 ). This was absent in the untransfected parent cells, although it can be strongly activated by apoptotic stimuli such as TNF plus actinomycin D (17) . However, cells of H1 and H2 clones did not show morphological signs of apoptosis and their proliferation rate was analogous to that of the control cells (Fig 5C) .
To have insight on the H-ferritin role under conditions of altered iron availability, we incubated the cells with 1 mM FAC for 18 h, conditions that are marginally toxic for HeLa cells.
MTT assay showed that the treatment did not modify significantly the viability of untransfected HeLa cells, while it decreased of about 30% that of H1 clone (Fig. 5C) . The treatment caused an increase of H-(6-fold) and L-ferritin (8-fold) in the control cells, while in H1 clone the increase was of 3-and 16-fold, respectively (Table I) . Next, we incubated the cells with 0.1 mM desferrioxamine (DFO) for 2 days, conditions that cause 10% mortality in untransfected HeLa cells, as monitored by Tripan blue exclusion (Fig. 5D) . In contrast, cell mortality was about 40% in the H1 clone (Fig. 5D) . Thus, stable H-ferritin suppression decreased cell resistance to iron excess and chelation.
Discussion
Functionality of the siRNAs. We found that 7 out of 8 siRNAs analyzed were effective in reducing the expression of the targeted ferritin down to about 20-25% of the background level.
Specificity was assessed by the lack of inhibition of the non-targeted ferritin. The same repression level was obtained with other three siRNAs complementary for the 5'UTR region of L-ferritin designed to inhibit specifically the endogenous protein but not the transfectant one, which lacks the 5'UTR (not shown). A similar repression level was obtained in the stably transfected H1 clone suggesting that the effectiveness of the siRNAs reaches saturation at about 80% repression. This finding contrasts with higher level of siRNA-dependent suppression (> 90%) observed for other genes (30) and may be related to the relative abundance and/or to the high stability of H-and Lferritin mRNAs (31) . Alternatively, siRNAs might target only the free and not the IRPs-bound ferritin mRNAs (28) . However, this hypothesis is not supported by the finding that iron supplementation, which decreases the IRPs-bound mRNA pool, stimulated H-ferritin expression in the H1 clone (~3 fold increase) even less than in control HeLa cells (~5-fold increase) ( Table I ).
All together the results suggest that ferritin siRNA silencing is more efficient than antisense oligonucleotide suppression, which accounted to 50-60% inhibition (14, 15) , although the data were obtained on different cells lines and a direct comparison may be difficult.
Role of L-ferritin. L-ferritin is ubiquitous in mammalian cells
, and is the major constituent of serum ferritin. Its role in regulating iron homeostasis and availability is unclear. To study it, we used transfection with siRNAs and cDNA to modify L-ferritin accumulation over a 13-fold range (Table I) . L-ferritin suppression did not affect the levels of the partner H-ferritin, demonstrating the specificity of L-siRNAs. More important, L-ferritin modulation, in either direction did not affect TfR1 levels, IRPs activity (Table I and Fig. 2A-B) and cell resistance to H 2 O 2 damage (Fig. 3A) .
The simplest interpretation of these findings is that L-ferritin levels do not modify the size of the labile iron pool, which is known to regulate the three proteins and the resistance to H 2 O 2 (13) . A minor additional repression of TfR1 was observed when L-ferritin was suppressed together with Hferritin (Fig. 2B) , and this is consistent with in vitro evidence that L-chain assists H-chain in increasing ferritin iron incorporation (10, 13) . In fact, it was already reported that the co-repression of H-and L-ferritins by antisense oligonucleotides produced stronger cellular effects than the repression by single H-antisense (15) . The lack of an evident role of L-ferritin in the regulation of iron metabolism, indicated by our cellular models, is in agreement with the clinical data showing that the systemic overexpression of L-ferritin in hereditary hyperferritinemia cataract syndrome has no evident effect on iron homeostasis (32) . It is also consistent with recent finding that the constitutive downregulation of L-ferritin in a subject with a disabling mutation in the L-chain start For personal use only. on April 14, 2017. by guest www.bloodjournal.org From codon had no evident effect on iron metabolism (33) . However, a rare and dominant disorder named neuroferritinopathy was recently described (34) . It is associated with an adenine insertion at position 460-461 in the coding region of L-ferritin, and the affected subjects show late-onset movement disorders and iron deposition in the brain basal ganglia. This suggests that changes in L ferritin modify iron metabolism in cells of CNS, although this is more likely caused by abnormal properties of the mutant protein than by haploinsufficiency.
A new and unexpected finding was that HeLa cell proliferation rate was positively modulated by L-ferritin levels. It increased of ~1.5-fold in the L-clone and was halved after LsiRNA silencing (Fig. 4A and B) . This is intriguing, since also H-ferritin level affects cell proliferation, but it does it in the opposite direction, possibly by limiting iron availability to cyclin dependent kinases or enzymes of DNA synthesis (13, 15) . In fact, this H-ferritin activity was abolished by inactivating its ferroxidase center or by supplementing the cells with iron (13) . On the other hand, L-ferritin has no ferroxidase activity, did not modify cellular iron availability and its pro-proliferative effect was not modified by cellular iron supplementation. Thus, H-and L-ferritins act on cell proliferation with different mechanisms. The finding that the two ferritins have opposite effects may help to explain why iron supplementation, which induces both of them, did not modify cell proliferation in HeLa cells (e.g. the control of Fig. 5C ). However, one may expect that the two act in concert when the level of only one ferritin type is modified. For example, transient transfection with H-siRNA increased ~20% MTT proliferation (Fig. 4C) , an effect that we mainly attributed the indirect L-chain upregulation. In fact the co-transfection with L -siRNA not only completely abolished it, but also reduced MTT proliferation to levels even lower than those obtained with L-siRNA (Fig. 4C) . This suggests that L-ferritin downregulation may contribute to the repression of cell proliferation caused by H-ferritin upregulation (13) . This finding may be biologically relevant, since TNF-and other cytokines modulate specifically H-ferritin (35) , and Lferritin expression varies during monocyte differentiation (36) . We may remind that a stimulatory effect on cell proliferation following L-rich ferritin addition to cultured cells has been observed before (37, 38) . Iron incorporation is the only L-ferritin function so far established by in vitro study (3) , but this does not seem to be involved in the pro-proliferation activity. This suggests that Lferritin affects some cellular pathways that remain to be identified.
Role of H-ferritin.
The use of siRNAs to transiently repress H-ferritin confirmed the data previously obtained by upregulating H-ferritin with cDNA transfection in HeLa cells (11) , and were in large agreement with those obtained by suppressing the protein with antisense desoxyoligonucleotides in K562 and in HEK-293 cells (14, 37) . Namely, H-ferritin level through its ferroxidase activity regulates primarily cell iron availability, and this has secondary effects on the (13) . An interesting advantage of siRNAs is the possibility to downregulate various genes at the same time: we demonstrated it on H-and Lferritins, and preliminary data indicate that it can be extended to TfR1 and other proteins of iron metabolism. So, this technology may be used to pinpoint the specific role of various proteins in regulating iron homeostasis. We previously observed that transient and stable H-ferritin cDNA transfections produce results dramatically different (11,13), therefore we worked to produce cell lines stably transfected with H-siRNA. We succeeded in obtaining such clones, and we analyzed the ones with the lowest level of H-ferritin. Surprisingly, the major parameters of iron availability, i.e. L-ferritin (Table I ) and TfR1 levels (Fig. 5 B) were essentially unchanged in the clones compared to control. This contrasted with the transiently transfected cells, where the same degree of H-ferritin suppression modified the indices and increased iron availability. The finding indicates the activation of long-term mechanisms that compensate for the stable reduction of H-ferritin ferroxidase activity.
The existence of such compensatory mechanisms has already been suggested by the study of cells transfected with IRP1 cDNA (40) . The finding may go someway to explain why different tissues and cell lines maintain normal iron availability even with different levels of H-ferritin. For example, H-ferritin +/-knockout mice have normal iron metabolism, despite a large reduction of systemic Hferritin level, and the only observed phenotype was an L-ferritin increase (41) , compatible with that we observed in the H1 clone.
A novel indication on the biological role of H-ferritin comes from the finding that H1 clone showed a reduced resistance to both iron supplementation and chelation ( Fig. 5C and 5D ).
This might be due to the modification of ferritin stability caused by altered iron availability (42) .
Alternatively, and more likely, it can be interpreted as H-ferritin acting as an iron buffer: low concentrations are sufficient to regulate iron availability under stationary conditions, but they reduce the cell capacity to respond to fast modifications of iron availability. This may occur because the ferroxidase activity of H-chain becomes insufficient to incorporate and detoxify the iron in excess, and because the reduced ferritin level cannot supply sufficient iron in response to chelation. Based on the available data we postulate that cellular H-ferritin level is regulated on the basis of the needs to respond to fast modifications of iron homeostasis, and should be maintained below a (un-physiological) threshold above which apparent iron deficiency occurs, as in the Hclone (13) . The hypothesis predicts that erythroid cells and macrophages, which are exposed to fast iron influxes, are rich in H-ferritin, as it occurs. However, other factors should be taken into account, for example low levels of H-ferritin seem to make H1 cells more sensitive to apoptosis, indicated by the signs of activated caspases, and by the higher killing effects of chelators, which are pro-apoptotic agents (43) .
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